News Medical on MSN8h
New clinical trial offers hope for patients with rare immune disease IgG4-RDA team led by Mass General Brigham researchers demonstrated that inebilizumab reduced the risk of symptoms by 87% in patients with the rare affliction known as immunoglobulin G4–related disease (IgG4- ...
Arrowhead Pharmaceuticals, Inc. today announced that it submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for investigational plozasiran for the treatment of ...
Arrowhead Pharmaceuticals, Inc. today announced new results from the Phase 3 PALISADE study and the open-label extension from the Phase 2 MUIR and SHASTA-2 studies of investigational plozasiran. These ...
Medical Xpress on MSN40m
Diabetes drug shows promise in protecting kidneysType 2 diabetes can lead to diabetic kidney disease, but a class of drugs that cause the kidneys to remove glucose through urine has been gaining attention. An Osaka Metropolitan University-led ...
New research shows that weight loss medications can stop the progression of prediabetes. Experts don’t all agree on such a ...
An intensive treatment ... 2 diabetes are estimated to also have high blood pressure, according to the U.S. Centers for Disease Control and Prevention data, and when blood pressure levels are ...
Twisted Sifter on MSN23h
New Study Finds Promising Treatment For Type-1 Diabetes Using Patient’s Own Stem CellsAccording to a new study, however, that may be changing. The team of researchers in China came up with a treatment that used ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback